Dutasteride, tamsulosin, alfuzosin and dutasteride/tamsulosin combination for treating benign prostatic hyperplasia

Published on 02 Jul 2018
Last Updated on 01 Apr 2025

Dutasteride, tamsulosin, alfuzosin and dutasteride/tamsulosin combination for treating benign prosthetic hyperplasia Guidance is outdated and has been withdrawn on 1 April 2025.

Treatments for benign prostatic hyperplasia (Withdrawn 1 Apr 2025) [PDF, 52 KB]